InsiderTrades

Form 4 for SVV Savers Value Village, Inc.

Accepted 2025-12-22 00:00:00 ET · period of report 2025-12-18 · accession 0001977272-25-000005 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-12-22 2025-12-18 SVV Tanious Jubran N. Pres, COO F - Tax $9.34 -25.2K 157.4K -14% -$235.4K
D 2025-12-22 2025-12-18 SVV Tanious Jubran N. Pres, COO S - Sale+OE $9.21 -57.7K 99.7K -37% -$531.5K
DM 2025-12-22 2025-12-18 SVV Tanious Jubran N. Pres, COO M - OptEx $1.41 +182.6K 182.6K +431,328% +$257.4K
DM 2025-12-22 2025-12-18 SVV Tanious Jubran N. Pres, COO M - OptEx $1.41 -182.6K 240.4K -43% -$257.4K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-12-18 F D 25,205 $9.34 157,418.33 D — —
2 Common Common Stock 2025-12-18 S D 57,706 $9.21 99,712.33 D — — (F1) This price represents the weighted average price per share of common stock of Savers Value Village, Inc. These Shares were executed at a range of prices from $9.140 to $9.341. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.
3 Common Common Stock 2025-12-18 M A 24,476 $1.41 24,518.33 D — —
4 Common Common Stock 2025-12-18 M A 46,822 $1.41 71,340.33 D — —
5 Common Common Stock 2025-12-18 M A 111,283 $1.41 182,623.33 D — —
6 Derivative Option (Right to Purchase) 2025-12-18 M D 111,283 $1.41 100,000 D $1.41 · — to 2029-11-01 111,283 Common Stock (F2) Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions. (F6) The total outstanding excludes the portion of the original option grant that was solely performance-based, which will be reported separately. (F7) The November 1, 2019 stock option grant vested in substantially equal annual installments over five years starting November 1, 2020 until fully vested on November 1, 2024.
7 Derivative Option (Right to Purchase) 2025-12-18 M D 46,822 $1.41 100,000 D $1.41 · — to 2029-06-12 46,822 Common Stock (F2) Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions. (F6) The total outstanding excludes the portion of the original option grant that was solely performance-based, which will be reported separately. (F5) The June 12, 2019 stock option grant vested in substantially equal annual installments over five years starting March 28, 2020, and was fully vested on March 28, 2024.
8 Derivative Option (Right to Purchase) 2025-12-18 M D 24,476 $1.41 240,365 D $1.41 · — to 2029-06-12 24,476 Common Stock (F2) Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions. (F4) The total outstanding excludes the portion of the original option grant that was solely time-based, which will be reported separately. (F3) The June 12, 2019 stock option grant vested 25% upon the initial public offering , 25% vested in June 2024 and the remainder will be eligible for vesting upon satisfaction of certain performance criteria including stock price performance.